PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study

BACKGROUND: To evaluate the efficacy and safety of pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF) in preventing neutropenia during multiple cycles of chemotherapy in patients with non–small cell lung cancer (NSCLC). METHOD: In a multicenter, prospective, randomized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xu‐Sheng, Wang, Zhe, Ren, Shu‐Hua, Zhang, He‐Lin, Liu, Li‐Jun, Du, Hong‐Bo, Liu, Xiao‐Wei, Liu, Jun‐Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436658/
https://www.ncbi.nlm.nih.gov/pubmed/35859328
http://dx.doi.org/10.1111/1759-7714.14544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436658/
https://www.ncbi.nlm.nih.gov/pubmed/35859328
http://dx.doi.org/10.1111/1759-7714.14544

Ejemplares similares